Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2
NCT ID: NCT05345184
Last Updated: 2025-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2022-09-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavioral Suicide Prevention for Psychosis: Aim 1
NCT04689867
Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy
NCT00791440
Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis
NCT03970005
Enhancing the Prospective Prediction of Psychosis
NCT00291200
Improving Negative Symptoms of Psychosis In Real-world Environments
NCT02170051
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavioral Suicide Prevention for psychosis (treatment group)
Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) is a behavioral treatment and will be delivered in 10 weekly individual therapy sessions in addition to standard/current services.
Cognitive Behavioral Suicide Prevention for psychosis (CBSPp)
Cognitive and behavioral approach to suicide prevention tailored for individuals with psychosis
Services as Usual (SAU; comparison group)
Services as usual involve standard and current services that clients are eligible for receiving.
Services as Usual (SAU)
Standard psychiatric and behavioral services provided at community mental health (e.g., case management, medication management)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Behavioral Suicide Prevention for psychosis (CBSPp)
Cognitive and behavioral approach to suicide prevention tailored for individuals with psychosis
Services as Usual (SAU)
Standard psychiatric and behavioral services provided at community mental health (e.g., case management, medication management)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suicide ideation and/or attempt within 3 months of screening
* Ability to speak and read in English
* 18 to 65 years of age
Exclusion Criteria
* Inappropriate for behavioral treatment according to own judgment in consultation with a treating clinician CMH
* Impaired capacity (cognitive capacity)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lindsay Bornheimer
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00211008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.